Blogs

MRSA in U.S. becoming resistant to over the counter ointment – The Chart - CNN.com Blogs

Frequent use of over-the-counter anti-bacterial ointments in the United States may be leading to a new, antimicrobial resistant strain of MRSA, a study published Wednesday in Emerging Infectious Diseases, the Centers for Disease Control and Prevention’s monthly peer-reviewed journal.

Good Signs Abound for Forest's New Antibiotic -- Seeking Alpha

<strong><a href='http://www.epvantage.com/'>EP Vantage</a>submits:</strong><p>Forest Laboratories’ (<a href='http://seekingalpha.com/symbol/frx' alt='Forest Laboratories Inc.' title='Forest Laboratories Inc.'>FRX</a>) ceftaroline received a surprisingly unanimous backing Tuesday from an FDA

Something fishy about this antibiotic scare

Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive Medicine Politics Practice Ideas Other stuff Jobs Search [BLOG HOMEPAGE] Something fishy about this antibiotic scare By

Antibiotics administered to patients may lead to higher levels of infection — Irish Medical Times

February 5, 2012 Home Contact Us About Us Subscribe Advertising Terms of Use Privacy Policy Sitemap RSS Feeds Irish Medical Times News Opinion Features Editorial Letters Blogs Clinical Times MIMS Ireland Lifestyle Jobs Events Small ads You are here: Home / Blogs / Hospital Medicine / Antibiotics

Common Questions about Middle Ear Infections « Family Webicine

Stories from behind the examining room door, as told by Rod Moser, PA, a primary care physician assistant with more than 35 years of clinical experience.

Blog. Antibiotics Enhance RNAi Capabilities

Researchers at the Emory University School of Medicine have discovered that fluoroquinolone antibiotics can make RNAi more effective in the laboratory and reduce potential side effects. The most power

Optimer Delivers Winning Punch in Fight Against Bacterial Infections -- Seeking Alpha

<strong><a href='http://www.prohostbiotech.com/'>Prohost Biotech</a>submits:</strong><p><span>The challenges raised by the pathologic strains of<i>Clostridium difficile</i>, and the failure of current treatments to contain infection recurrence, is the reason for our enthusiasm about the positive

Cubist Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript -- Seeking Alpha

<p>Cubist Pharmaceuticals, Inc. (<a href='http://seekingalpha.com/symbol/cbst' title='More opinion and analysis of CBST'>CBST</a>)</p><p>Q4 2009 Earnings Call Transcript</p><p>January 21, 2009 5:00 pm ET</p><br/><a

MiddleBrook Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript -- Seeking Alpha

<p>MiddleBrook Pharmaceuticals, Inc. (<a href='http://seekingalpha.com/symbol/mbrk' title='More opinion and analysis of MBRK'>MBRK</a>)</p><p>Q3 2009 Earnings Call</p><p>November 5, 2009 9:00 am ET</p><br/><a

Cubist Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript -- Seeking Alpha

<p>Cubist Pharmaceuticals, Inc. (<a href='http://seekingalpha.com/symbol/cbst' title='More opinion and analysis of CBST'>CBST</a>)</p><p>Q3 2009 Earnings Call</p><p>October 15, 2009 5:00 pm ET</p><br/><a

Results 1-10 of 35
 


Refine by Content Type:

  • Refined by: Blogs  


Refine by Source:

6 Sources ...